BIOTAP Medical is now providing SARS-CoV-2 (COVID-19) testing in response to the urgent need for additional testing by CLIA-certified, high-complexity laboratories.
IF YOU ARE EXPERIENCING COVID-19 SYMPTOMS, PLEASE CALL YOUR HEALTHCARE PROVIDER OR THE KENTUCKY COVID-19 HOTLINE AT 1-800-722-5725
If You Are A Patient
Please coordinate all SARS-CoV-2 (COVID-19) testing with your physician to ensure the proper procedures and processes are followed for testing, diagnosis, and treatment.
If You Are A Provider
BIOTAP Medical’s SARS-CoV-2 (COVID-19) test uses Nucleic Acid Amplification (NAA) and real-time RT-PCR. With this state-of-the art technology, the testing is able to provide practitioners with proper identification of the virus within 24-48 hours (dependent on testing prioritization based on CDC guidelines), thereby decreasing the time to treatment initiation and helping to mitigate the spread of the novel coronavirus.
BIOTAP Medical accepts the following specimens:
Test specimens must be received within 72 hours of collection.
Specimens should be shipped at a temperature of 2-8° C, preserved in ice packs.
If specimen storage of more than 72 hours is required, specimens should be frozen at -70° C or packed in dry ice.
BIOTAP Medical may reject SARS-CoV-2 specimens if they meet any of the following criteria:
x Stored at room temperature for more than 24 hours after collection
x Refrigerated for more than 72 hours after collection
x Improper labeling
x Excessive contamination
x Broken or leaking packaging or transport device
x Use of cotton-tipped swabs
x Use of swabs that contain a preservative
x Use of wooden-shafted swabs
BIOTAP Medical's testing results will indicate one of three results:
POSITIVE: SARS-CoV-2 (COVID-19) virus was detected in the specimen
NOT DETECTED: SARS-CoV-2 (COVID-19) virus was not detected in the specimen
INDETERMINATE: Unable to determine a result; recollect a new specimen
Test Details and Specifications
The BIOTAP Medical SARS-CoV-2 (COVID-19) test is a multiplex real-time RT-PCR assay intended for the qualitative detection of nucleic acid from SARS-CoV-2 in individuals meeting the Centers for Disease Control (CDC) COVID-19 clinical criteria (e.g., clinical signs and symptoms associated with SARS-CoV-2 infection) in conjunction with CDC COVID-19 epidemiological criteria or other epidemiologic criteria for which SARS-CoV-2 testing may be indicated. This test has been authorized by the FDA under an Emergency Use Authorization (EUA).
BIOTAP Medical has been performing molecular infectious disease testing prior to the current COVID-19 health crisis. The decision to provide SARS-CoV-2 testing was the right thing to do for both our clients and the community. If you need additional information, we encourage you to review the resources below.
For additional information and updates, BIOTAP Medical recommends viewing the following resources:
Download our SARS-CoV-2 (COVID-19) Anterior nares (NS) testing and shipping procedure guidelines here.
Download our SARS-CoV-2 (COVID-19) Nasopharyngeal (NP) testing and shipping procedure guidelines here.
About BIOTAP Medical
BIOTAP Medical is a respected leader in the field of clinical laboratory medicine. The lab is federally certified by CLIA to perform high-complexity diagnostic testing with some of the most advanced technology in the business. Our vision is to advance laboratory diagnostics and the science of patient care, while upholding the values of accessibility, expertise, innovation, and humanity.
BIOTAP Medical works with Medicare and Medicaid beneficiaries
as well as patients insured through private payers.
Located in downtown Louisville, KY, BIOTAP has served the region since 2012.